Reprogramming energetic metabolism in Alzheimer's disease

被引:31
|
作者
Vallee, Alexandre [1 ]
Lecarpentier, Yves [2 ]
Guillevin, Remy [3 ,4 ]
Vallee, Jean-Noel [1 ,5 ]
机构
[1] Univ Poitiers, LMA, UMR CNRS 7348, CHU Poitiers, Poitiers, France
[2] GHEF, Ctr Rech Clin, Meaux, France
[3] Univ Poitiers, DACTIM, UMR CNRS 7348, LMA, Poitiers, France
[4] CHU Poitiers, Poitiers, France
[5] UPJV, CHU Amiens Picardie, Amiens, France
关键词
WNT/beta-catenin pathway; PPAR gamma; circadian rhythms; Alzheimer's disease; oxidative stress; inflammation; ACTIVATED RECEPTOR-GAMMA; WNT/BETA-CATENIN PATHWAY; TRANSGENIC MOUSE MODEL; CANONICAL WNT PATHWAY; CLOCK GENE-EXPRESSION; PPAR-GAMMA; AMYLOID-BETA; OXIDATIVE STRESS; CIRCADIAN CLOCK; MITOCHONDRIAL DYSFUNCTION;
D O I
10.1016/j.lfs.2017.10.033
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Entropy rate is increased by several metabolic and thermodynamics abnormalities in neurodegenerative diseases (NDs). Changes in Gibbs energy, heat production, ionic conductance or intracellular acidity are irreversibles processes which driven modifications of the entropy rate. The present review focusses on the thermodynamic implications in the reprogramming of cellular energy metabolism enabling in Alzheimer's disease (AD) through the opposite interplay of the molecular signaling pathways WNT/beta-catenin and PPAR gamma. In AD, WNT/beta-catenin pathway is downregulated while PPAR gamma is upregulated. Thermodynamics behaviors of metabolic enzymes are modified by dysregulation of the canonical WNT/beta-catenin pathway. Downregulation of WNT/beta-catenin pathway leads to oxidative stress and cell death through inactivation of glycolytic enzymes such as Glut, PKM2, PDK1, MCT-1, LDH-A but activation of PDH. In addition, in NDs, PPAR gamma is dysregulated whereas it contributes to the regulation of several key circadian genes. AD is considered as a dissipative structure that exchanges energy or matter with its environment far from the thermodynamic equilibrium. Far-from-equilibrium thermodynamics are notions driven by circadian rhythms. Circadian rhythms directly participate in regulating the molecular pathways WNT/beta-catenin and PPAR gamma involved in the reprogramming of cellular energy metabolism enabling AD processes.
引用
收藏
页码:141 / 152
页数:12
相关论文
共 50 条
  • [41] Amyloid metabolism and secretases in Alzheimer's disease.
    Xia W.
    Current Neurology and Neuroscience Reports, 2001, 1 (5) : 422 - 427
  • [42] Lipid metabolism and Alzheimer's disease: pathways and possibilities
    Saxena, Uday
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (03) : 331 - 338
  • [43] Multiple Defects in Energy Metabolism in Alzheimer's Disease
    Ferreira, I. L.
    Resende, R.
    Ferreiro, E.
    Rego, A. C.
    Pereira, C. F.
    CURRENT DRUG TARGETS, 2010, 11 (10) : 1193 - 1206
  • [44] Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease
    Martins, Ian J.
    Berger, Tamar
    Sharman, Matthew J.
    Verdile, Giuseppe
    Fuller, Stephanie J.
    Martins, Ralph N.
    JOURNAL OF NEUROCHEMISTRY, 2009, 111 (06) : 1275 - 1308
  • [45] Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease
    Whiley, Luke
    Sen, Arundhuti
    Heaton, James
    Proitsi, Petroula
    Garcia-Gomez, Diego
    Leung, Rufina
    Smith, Norman
    Thambisetty, Madhav
    Kloszewska, Iwona
    Mecocci, Patrizia
    Soininen, Hilkka
    Tsolaki, Magda
    Vellas, Bruno
    Lovestone, Simon
    Legido-Quigley, Cristina
    NEUROBIOLOGY OF AGING, 2014, 35 (02) : 271 - 278
  • [46] Brain fuel metabolism, aging, and Alzheimer's disease
    Cunnane, Stephen
    Nugent, Scott
    Roy, Maggie
    Courchesne-Loyer, Alexandre
    Croteau, Etienne
    Tremblay, Sebastien
    Castellano, Alex
    Pifferi, Fabien
    Bocti, Christian
    Paquet, Nancy
    Begdouri, Hadi
    Bentourkia, M'hamed
    Turcotte, Eric
    Allard, Michele
    Barberger-Gateau, Pascale
    Fulop, Tamas
    Rapoport, Stanley I.
    NUTRITION, 2011, 27 (01) : 3 - 20
  • [47] Amyloid-β and Glucose Metabolism in Alzheimer's Disease
    Furst, Ansgar J.
    Lal, Rayhan A.
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 26 : 105 - 116
  • [48] Alteration of the metabolism of membrane phospholipids in Alzheimer's disease
    Gattaz, WF
    Levy, R
    Cairns, NJ
    Forstl, H
    Braus, DF
    Maras, A
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 1996, 64 (01) : 8 - 12
  • [49] Lipid metabolism, epidemiology, and the mechanisms of Alzheimer's disease
    Friedland, RP
    ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY, 2002, 977 : 387 - 390
  • [50] Cholesterol at the crossroads: Alzheimer's disease and lipid metabolism
    Wellington, CL
    CLINICAL GENETICS, 2004, 66 (01) : 1 - 16